Ravi Paruparla, Manisha Lalan, Pranav Shah, Nupur Vasdev
{"title":"A critical comparative insight on nanocarrier-based intranasal delivery of statins for neuroprotective applications.","authors":"Ravi Paruparla, Manisha Lalan, Pranav Shah, Nupur Vasdev","doi":"10.1080/10837450.2026.2614071","DOIUrl":"10.1080/10837450.2026.2614071","url":null,"abstract":"<p><p>The incidence of central nervous system (CNS) disorders is rising globally, particularly as the prevalence of neurodegenerative diseases increases. The primary challenge in such cases is limited transport of therapeutics through the blood-brain barrier (BBB). Statins, widely used for hypercholesterolemia, exhibit pleiotropic neuroprotective effects; however, their therapeutic potential in CNS disorders is restricted by poor brain bioavailability with conventional routes. Intranasal (IN) delivery has long been recognized as a plausible pathway for brain targeting. This narrative review critically examines preclinical literature on IN nanocarrier-based delivery systems developed specifically for statins, with emphasis on nose-to-brain transport, formulation strategies, pharmacokinetics (PK), and neuroprotective outcomes. This work uniquely integrates a formulation-centric comparison of IN nanocarriers for statins. It highlights the potential of IN delivery, discussing the influence of carrier type, physicochemical properties, and delivery strategy on brain targeting efficiency and therapeutic relevance across different neurological indications. IN nanocarrier systems display potential to enhance statin brain delivery by bypassing the BBB and first-pass metabolism. Nevertheless, current evidence is predominantly preclinical, with significant variability in study design, pharmacokinetic reporting, and safety evaluation. Translation to clinics will require standardized nose-to-brain metrics, long-term safety studies, scalable manufacturing processes, and early regulatory alignment.</p>","PeriodicalId":20004,"journal":{"name":"Pharmaceutical Development and Technology","volume":" ","pages":"211-232"},"PeriodicalIF":2.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145960068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Chuanxu Luo, Linlin Zhao, Yu Chen, Xiaoyuan Liu, Jiamin Mao, Jing Ye, Lie Zhang, Yucheng Xiang, Xiaohong Xu, Xi Fu, Quan Zhang
{"title":"Morin-loaded water-soluble nanomicelles as a novel anti-alcohol intoxication medication.","authors":"Chuanxu Luo, Linlin Zhao, Yu Chen, Xiaoyuan Liu, Jiamin Mao, Jing Ye, Lie Zhang, Yucheng Xiang, Xiaohong Xu, Xi Fu, Quan Zhang","doi":"10.1080/10837450.2026.2617346","DOIUrl":"10.1080/10837450.2026.2617346","url":null,"abstract":"<p><p>Acute alcohol intoxication (AAI) poses serious health risks. Currently, no approved therapy effectively treats both CNS depression and tissue damage in AAI. Standard care, including supportive measures and off-label naloxone, manages respiratory depression but fails to prevent oxidative organ injury. We identified morin (MOR) as a promising candidate for addressing these challenges. Given that MOR is limited by poor water solubility and low oral bioavailability, we developed water-soluble nano-micelle formulations (MOR-Ms) using Kolliphor HS15 (HS15) as a surfactant for intravenous administration. The resulting MOR-Ms exhibited a uniform size of 13.84 ± 0.23 nm and a zeta potential of -9.99 ± 0.21 mV. <i>In vivo</i>, MOR-Ms accelerated alcohol metabolism by enhancing hepatic enzyme activity. In an AAI mouse model induced by intraperitoneal injection of 50% alcohol (10 ml/kg), MOR-Ms (3 mg/kg) significantly shortened the duration of loss of righting reflex (LORR) by 58.01%, which was comparable to the 67.83% reduction achieved by naloxone (1 mg/kg). Furthermore, MOR-Ms markedly lessened tissue damage by decreasing malondialdehyde (MDA) levels (by 32.01% in liver and 53.75% in brain compared to the model group) and boosting antioxidant enzyme activity. These results highlight the potential of MOR-Ms as a promising therapeutic approach for AAI.</p>","PeriodicalId":20004,"journal":{"name":"Pharmaceutical Development and Technology","volume":" ","pages":"282-293"},"PeriodicalIF":2.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145966300","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Omnia M Sarhan, Eman M El-Noby, Hasnaa A El-Shaat, Mostafa S A Mostafa, Mostafa I Gebril
{"title":"Comparative in vivo assessment of hair-growth efficacy using nanostructured lipid carriers individually loaded with lavender oil or tea seed oil.","authors":"Omnia M Sarhan, Eman M El-Noby, Hasnaa A El-Shaat, Mostafa S A Mostafa, Mostafa I Gebril","doi":"10.1080/10837450.2026.2618489","DOIUrl":"10.1080/10837450.2026.2618489","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to formulate nanostructured lipid carriers loaded with tea seed or lavender oil to enhance hair regrowth <i>via</i> improved follicular penetration, as an alternative to conventional alopecia therapies.</p><p><strong>Methodology: </strong>NLCs were prepared by ultrasonication of stearic acid: essential oil mixtures into an aqueous phase containing either Tween 80 or Pluronic F127 as surfactants. Particle size, polydispersity index, zeta potential and TEM were measured. <i>In vivo</i> efficacy was evaluated in female Wistar albino rats given selected once-daily topical NLCs for 30 days.</p><p><strong>Key results: </strong>DLS analysis showed that formulations F2 and F5 had mean particle sizes of 165 ± 3 nm and 181 ± 6 nm, respectively, whereas the mixed-oil formulation F3 aggregated into large droplets. Zeta potentials of -65 ± 2 mV (F2) and -42 ± 3 mV (F5) confirmed excellent electrostatic stability. TEM images verified roughly spherical, core-shell nanoparticles. In the <i>in vivo</i> study, F2 and F5 treatments increased mean hair lengths by 120% and 132% versus placebo (<i>p</i> < 0.001), respectively, compared to a 116% increase with the commercial product. NLCs significantly enhanced follicular density, with the lavender oil formulation showing superior hair shaft integrity.</p><p><strong>Conclusion: </strong>These results demonstrate that Pluronic F127-stabilized NLCs carrying natural oils possess optimal physicochemical properties and promote hair regrowth.</p>","PeriodicalId":20004,"journal":{"name":"Pharmaceutical Development and Technology","volume":" ","pages":"294-306"},"PeriodicalIF":2.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145998758","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Nanozyme-based therapeutics: bridging catalysis and nanomedicine.","authors":"Abhay Thakur, Rohit Sharma, Rahul Sharma, Kakarla Pakeeraiah","doi":"10.1080/10837450.2026.2620469","DOIUrl":"10.1080/10837450.2026.2620469","url":null,"abstract":"<p><p>Nanozymes are engineered nanoparticles that mimic enzyme-like catalytic activities and have gained significant attention in bioanalytical and biomedical applications. A broad range of nanomaterials has been explored for their intrinsic catalytic properties, and with suitable optimization, these systems can exhibit enzyme-comparable activity in biological environments. Consequently, nanozymes offer substantial potential as versatile catalytic platforms in nanomedicine. This review highlights recent advances in nanozyme research, emphasizing mechanistic understanding rather than strict kinetic equivalence to natural enzymes. Fundamental catalytic principles, including electron transfer, redox cycling, and surface-confined active-site behavior, are discussed to elucidate nanozyme function in complex biological systems. Particular focus is placed on the influence of structural features, surface functionalization, and cascade catalytic architectures on the activity of metal oxide- and carbon-based nanozymes. In addition, nanozymes responsive to tumor microenvironmental stimuli such as pH, hydrogen peroxide, and glutathione are examined for targeted redox modulation. Pharmacokinetic behavior and biosafety considerations are critically evaluated, addressing unresolved concerns related to long-term toxicity and biodistribution. Overall, nanozymes represent a promising class of catalytic nanomaterials for future nanomedicine platforms, provided systematic efforts ensure mechanistic rigor, standardized evaluation, and regulatory-aligned safety assessment.</p>","PeriodicalId":20004,"journal":{"name":"Pharmaceutical Development and Technology","volume":" ","pages":"307-323"},"PeriodicalIF":2.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146019004","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Surfactant-based drug delivery strategies for HIV/AIDS therapy: advances in formulation and clinical translation.","authors":"Karuppiah Nagaraj","doi":"10.1080/10837450.2025.2588416","DOIUrl":"10.1080/10837450.2025.2588416","url":null,"abstract":"<p><p>The present paper provides a detailed overview of surfactants' function in HIV/AIDS therapy, with a focus on medication administration, direct antiviral mechanisms, and microbicide formulations. The use of surfactant-based nanotechnology into antiretroviral therapy has resulted in the development of liposomes, polymeric micelles, nanoemulsions, and surfactant-modified biomaterials that provide controlled release and increased bioavailability of antiretrovirals. Furthermore, many surfactants have inherent antiviral activity, which disrupts the viral lipid envelope, inhibits viral replication, and prevents HIV from entering host cells. The paper also explores the potential of surfactant-based biosensors for HIV diagnostics, emphasizing their role in improving sensitivity and selectivity and recent progress in formulation design using surfactants such as sodium lauryl sulfate, poloxamers, and biosurfactants, emphasizing their safety, biocompatibility, and clinical potential. Key challenges including scalability, environmental impact, and user acceptability are discussed alongside emerging AI-driven approaches for personalized nanomedicine. Surfactant toxicity and limited biocompatibility remain key barriers. Developing safer, more effective surfactants is essential for future clinical progress.</p>","PeriodicalId":20004,"journal":{"name":"Pharmaceutical Development and Technology","volume":" ","pages":"1-33"},"PeriodicalIF":2.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145605728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Correction.","authors":"","doi":"10.1080/10837450.2025.2607906","DOIUrl":"10.1080/10837450.2025.2607906","url":null,"abstract":"","PeriodicalId":20004,"journal":{"name":"Pharmaceutical Development and Technology","volume":" ","pages":"182"},"PeriodicalIF":2.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145820388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mingming Wang, Zan Sun, Jian Hu, Qiaoyan Huang, Weifeng Long, Zhengjia Shen, Ya Li, Ping Wang
{"title":"Fabrication of baicalin solid dispersion using the supercritical anti-solvent technology: optimization, characterization, and evaluation.","authors":"Mingming Wang, Zan Sun, Jian Hu, Qiaoyan Huang, Weifeng Long, Zhengjia Shen, Ya Li, Ping Wang","doi":"10.1080/10837450.2025.2605689","DOIUrl":"10.1080/10837450.2025.2605689","url":null,"abstract":"<p><p>Baicalin is a flavonoid glycoside with substantial biological activity and pharmacological effects, primarily extracted from <i>Scutellaria baicalensis Georgi</i>. However, its clinical implementation has been impeded by suboptimal aqueous solubility and unfavorable bioavailability. This study employed a supercritical anti-solvent (SAS) process to prepare amorphous solid dispersions of baicalin, aiming to enhance its dissolution and bioavailability. The effects of supercritical temperature, supercritical pressure, and CO<sub>2</sub> flow rate on encapsulation were thoroughly investigated using the Box-Behnken Design (BBD) response surface methodology. SEM, FTIR, DSC, and XRD analyses confirmed that the baicalin solid dispersion prepared <i>via</i> the SAS method was in an amorphous state. <i>In vitro</i> dissolution tests indicated that the solubility of baicalin in the solid dispersion was 9.4 times (pH = 6.8) greater than that of the raw baicalin particles. Furthermore, rat experiments revealed that the bioavailability of baicalin in the solid dispersions was 1.8 times higher than that in traditional particles. Notably, BASD exhibited strong inhibitory effects on the growth of <i>Bacillus subtilis</i> and <i>Escherichia coli</i>. Consequently, a solid dispersion of baicalin was successfully prepared using the BBD-optimized SAS process, significantly enhancing the performance of baicalin.</p>","PeriodicalId":20004,"journal":{"name":"Pharmaceutical Development and Technology","volume":" ","pages":"116-132"},"PeriodicalIF":2.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145768739","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Maryam Maghsoodi, Mehdi Ezzati Nahand, Ali Nokhodchi
{"title":"Parabens potential as polymer additives in supersaturable formulations.","authors":"Maryam Maghsoodi, Mehdi Ezzati Nahand, Ali Nokhodchi","doi":"10.1080/10837450.2025.2612592","DOIUrl":"10.1080/10837450.2025.2612592","url":null,"abstract":"<p><p>This study aimed to assess two parabens, methylparaben and propylparaben, as additives to study their effects on the ability of the eudragit S100 (EU) in stabilizing the supersaturation of dipyridamole (DP). Capability of EU/parabens binary compositions to stabilize DP supersaturation was compared with EU/parabens physical mixtures to recognize the influence of parabens on the EU-mediated DP supersaturation stabilization. The interaction between EU and parabens was studied by FT-IR studies. For EU/parabens binary compositions, the capability of EU in supersaturation stabilization of DP increased compared with the EU alone. When the EU was physically blended with parabens, DP supersaturation was not affected by the presence of parabens. This demonstrated that the impact of parabens on the supersaturation of DP could not be attributed to a higher stabilization influence on DP supersaturation exerted by the combination of the EU and parabens, but rather may be attributed to the enhancement effect of parabens on the dissolution rate of EU. FT-IR results demonstrated intermolecular interactions between EU and parabens which may contribute to enhancing the dissolution rate of EU. The recently revealed supersaturation improvement found in the present study is interesting and has the benefit of providing a higher drug supersaturation maintenance by polymers through the use of suitable additives.</p>","PeriodicalId":20004,"journal":{"name":"Pharmaceutical Development and Technology","volume":" ","pages":"168-181"},"PeriodicalIF":2.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145900894","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Deep eutectic solvents as emerging carriers for antihyperlipidemic drugs: current trends and future perspectives.","authors":"Sushant Gaikwad, Ambar Marne, Ashwini Gawade, Ashwin Kuchekar","doi":"10.1080/10837450.2025.2611902","DOIUrl":"10.1080/10837450.2025.2611902","url":null,"abstract":"<p><p>The therapeutic effectiveness of the most antihyperlipidemic drugs, particularly Biopharmaceutics Classification system Class II drugs like statins, is severely limited by their low aqueous solubility and resulting low and variable oral bioavailability (e.g. ∼5% for simvastatin). Deep Eutectic solvents and Therapeutic Deep Eutectic System are explored in this review as an environmentally friendly and innovative next-generation platform designed to overcome these fundamental biopharmaceutical limitations. These systems function as good solubilizers, improving the dissolution rate and the thermodynamic stability of antihyperlipidemic drugs significantly. This directly enhances the drug absorption kinetics, resulting in more predictable and enhanced oral bioavailability. Commercialization of DESs still faces major challenges. Large-scale-up is difficult because their high viscosity reduces mixing and mass transfer efficiency. Also, a complete evaluation of their cytotoxicity, biodegradability, and long-term thermal stability is still needed to ensure their safe and sustainable use as effective pharmaceutical excipients.</p>","PeriodicalId":20004,"journal":{"name":"Pharmaceutical Development and Technology","volume":" ","pages":"133-155"},"PeriodicalIF":2.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145900902","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A comparative study of spray drying and jet milling in the preparation of nintedanib dry powder for inhalation.","authors":"Jingyu Shi, Hao Miao, Changhui Li, Zhenbo Tong","doi":"10.1080/10837450.2025.2611906","DOIUrl":"10.1080/10837450.2025.2611906","url":null,"abstract":"<p><p>This study optimized nintedanib dry powder for inhalation (DPI) and compared it with organic solvent-based spray drying and jet milling. A solid dispersion of nintedanib, polyvinyl alcohol (PVA), and leucine was produced by spray drying from an ammonium carbonate (Ab) aqueous solution. Formulation and process variables-API:(PVA+leucine (L)) mass ratio, PVA:L ratio, API: Ab ratio, total solids, and feed flow-were systematically screened to yield particles with geometric size ≤5 μm. Powders were characterized for morphology, moisture, density, particle size distribution, crystallinity, assay, and aerodynamic deposition. The optimized formulation showed good flowability and stability, with API content >80% in DPI particles; mass median aerodynamic diameter (MMAD) was 4.18 μm and fine particle fraction (FPF) 36.59%, indicating effective deep-lung delivery potential. Compared with conventional methods, the aqueous spray drying route delivered comparable or superior <i>in vitro</i> inhalation performance and delivery efficiency, while improving safety during the preparation and usage process (such as reducing the risk of organic solvent residue and dust exposure). These results provide a practical strategy for safe, efficient nintedanib inhalation formulations and a platform to spray dry other poorly water-soluble drugs into DPI particles.</p>","PeriodicalId":20004,"journal":{"name":"Pharmaceutical Development and Technology","volume":" ","pages":"156-167"},"PeriodicalIF":2.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145892872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}